Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More

Aurobindo Pharma Q4 PAT seen up 18.2% YoY to Rs. 624.9 cr: Prabhudas Lilladher

Net Sales are expected to increase by 25.9 percent Y-o-Y (down 3 percent Q-o-Q) to Rs. 5,020.7 crore, according to Prabhudas Lilladher.

April 12, 2019 / 12:45 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharma sector. The brokerage house expects Aurobindo Pharma to report net profit at Rs. 624.9 crore up 18.2% year-on-year (down 15.2% quarter-on-quarter).


Net Sales are expected to increase by 25.9 percent Y-o-Y (down 3 percent Q-o-Q) to Rs. 5,020.7 crore, according to Prabhudas Lilladher.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 30.2 percent Y-o-Y (down 2.4 percent Q-o-Q) to Rs. 968.2 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol News

stay updated

Get Daily News on your Browser
Sections